Renovaro BiosciencesRENB 
$0.640.31%24h
0.31%24h
Global rank26069
Market cap$36.01M
Change 7d-8.70%
YTD Performance-79.68%
SP500 benchmarkUnderperform
P/E-0.90
P/S0
Revenue$0
Earnings-$39.68M
Dividend yield-
Main Sector
Healthcare
Renovaro Biosciences Revenue data
According to Renovaro Biosciences latest financial reports the company had revenue of $0 in 2023-06-30, a NaN% decrease from 2022. Renovaro Biosciences highest revenue was $0 in 2023.
Revenue history for Renovaro Biosciences from 2020 to 2024
-
Value:-
Renovaro Biosciences revenue by year
| Year | Revenue | Change |
|---|---|---|
| 2023 | $0 | NaN% |
| 2022 | $0 | NaN% |
| 2021 | $0 | NaN% |
| 2020 | $0 | - |
View the top revenue stocks 
